Oral Vinorelbine and Capecitabine in Advanced HER2-negative Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: oral vinorelbine and capecitabine
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences